| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |